» Articles » PMID: 16169681

Radiotherapy for Early Glottic Carcinoma (T1N0M0): Results of Prospective Randomized Study of Radiation Fraction Size and Overall Treatment Time

Overview
Specialties Oncology
Radiology
Date 2005 Sep 20
PMID 16169681
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate in a prospective randomized study the effect of radiation fraction size and overall treatment time on the local control of early glottic carcinoma.

Methods And Materials: Between December 1993 and December 2001, 180 patients with early glottic carcinoma (T1N0M0) were treated at our department. The patients were randomly allocated to either treatment arm A (radiation fraction size 2 Gy, n = 89) or B (2.25 Gy, n = 91). The total radiation dose administered was 60 Gy in 30 fraction within 6 weeks for minimal tumors (two-thirds of the vocal cord or less) or 66 Gy in 33 fractions in 6.6 weeks for larger than minimal tumors (more than two-thirds of the vocal cord) in Arm A and 56.25 Gy in 25 fractions within 5 weeks for minimal tumor or 63 Gy in 28 fractions within 5.6 weeks for larger than minimal tumors in Arm B.

Results: The 5-year local control rate was 77% for Arm A and 92% for Arm B (p = 0.004). The corresponding 5-year cause-specific survival rates were 97% and 100% (no significant difference). No significant differences were found between these two arms in terms of rates of acute mucosal reaction, skin reactions, or chronic adverse reactions.

Conclusion: Use of 2.25-Gy fractions with a shorter overall treatment time for Arm B showed superior local control compared with conventional use of 2-Gy fractions for Arm A without adverse reactions from the greater fraction.

Citing Articles

Outcome of T2 Glottic Cancer Treated with Radiotherapy Alone or Concurrent Chemo-Radiotherapy.

Peng P, Lin C, Liao C, Wang H, Huang S, Tsai Y Cancers (Basel). 2025; 17(4).

PMID: 40002305 PMC: 11853244. DOI: 10.3390/cancers17040712.


A Dysfunctional Larynx Dilemma: Carcinoma Recurrence or Radiation-induced Damage?.

Soriano P, Cabungcal A, Villafuerte C, Lahoz A Acta Med Philipp. 2024; 57(11):97-101.

PMID: 39484066 PMC: 11522368. DOI: 10.47895/amp.vi0.4915.


Pencil Beam Scanning Proton Therapy as Single Vocal Cord Irradiation for Early-Stage Glottic Cancer.

Savla B, Jatczak J, Molitoris J, Witek M, Marter K, Zakhary M Int J Part Ther. 2024; 13:100623.

PMID: 39139470 PMC: 11321307. DOI: 10.1016/j.ijpt.2024.100623.


Targeting Anterior Commissure Involvement with Hyperfractionated Radiotherapy for T1-T2 Squamous Cell Carcinoma of the Glottic Larynx.

Seno S, Iwashita K, Kajiwara A, Sasaki R, Furukawa T, Teshima M Cancers (Basel). 2024; 16(10).

PMID: 38791929 PMC: 11119720. DOI: 10.3390/cancers16101850.


Accelerated Fractionated Radiation Therapy for Localized Glottic Carcinoma.

Mizukami T, Yamagishi K, Tobikawa M, Nakazato A, Abe H, Morita Y Curr Oncol. 2024; 31(5):2636-2643.

PMID: 38785479 PMC: 11119052. DOI: 10.3390/curroncol31050198.